If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to eMarketer. Obesity drugs have also started showing up in emp ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Key Insights Insiders appear to have a vested interest in ISDN Holdings' growth, as seen by their sizeable ownership ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where ...

The Capital Structure page of Cholamandalam Financial Holdings Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period. Capital Structure - ...

But the iconic "Sears" sign next to the shuttered department store – or, more specifically, the structure holding that sign – is likely to stay put. The company redeveloping the more than ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...